As we prepare for 2025, the life sciences industry faces evolving challenges, from regulatory scrutiny and drug pricing pressures to HCP engagement complexities. Join Baker Tilly’s fourth annual life sciences industry forecast webinar on Jan. 23 to uncover trends shaping the future. Explore emerging company strategies, leveraging technology to mitigate compliance risks, navigating gross-to-net challenges and more. Don’t miss this opportunity to gain actionable insights for the year ahead! https://bit.ly/4a9k9wd
Baker Tilly US’ Post
More Relevant Posts
-
As we prepare for 2025, the life sciences industry faces evolving challenges, from regulatory scrutiny and drug pricing pressures to HCP engagement complexities. Join Baker Tilly’s fourth annual life sciences industry forecast webinar on Jan. 23 to uncover trends shaping the future. Explore emerging company strategies for leveraging technology to mitigate compliance risks, navigating gross-to-net challenges and more. Don’t miss this opportunity to gain actionable insights for the year ahead! https://lnkd.in/efdXfwww
-
As we prepare for 2025, the life sciences industry faces evolving challenges, from regulatory scrutiny and drug pricing pressures to HCP engagement complexities. Join Baker Tilly’s fourth annual life sciences industry forecast webinar on Jan. 23 to uncover trends shaping the future. Explore emerging company strategies, leveraging technology to mitigate compliance risks, navigating gross-to-net challenges and more. Don’t miss this opportunity to gain actionable insights for the year ahead! https://lnkd.in/dHmrQ7vA
-
As we prepare for 2025, the life sciences industry faces evolving challenges, from regulatory scrutiny and drug pricing pressures to HCP engagement complexities. Join Baker Tilly’s fourth annual life sciences industry forecast webinar on Jan. 23 to uncover trends shaping the future. Explore emerging company strategies for leveraging technology to mitigate compliance risks, navigating gross-to-net challenges and more. Don’t miss this opportunity to gain actionable insights for the year ahead!
-
Join Baker Tilly on January 23rd for our fourth annual life sciences industry forecast webinar, where we will explore developments from this past year, discuss the current state of the environment and examine trends and challenges shaping the industry in 2025 and beyond! #LifeScience #BakerTilly
-
Join Baker Tilly for our fourth annual life sciences industry forecast webinar, where we will explore developments from this past year, discuss the current state of the environment and examine trends and challenges shaping the industry in 2025 and beyond. #NowForTomorrow
As we step into 2025, the life sciences sector finds itself well-funded for deals but also grappling with regulatory scrutiny, pricing pressures, and complex global HCP engagements. Join Baker Tilly’s fourth annual life sciences industry forecast webinar on Jan. 23 to discover the trends shaping the future. Learn about innovative strategies companies are adopting to address compliance risks, tackle gross-to-net challenges, and more. Don’t miss this opportunity to gain actionable insights for the year ahead! Michelle Kupka, Mark Scallon, John Rogula, Timothy Nugent, Samantha Sutherland, Mario Prohasky
-
In this edition of the New Medicines, Novel Insights newsletter, hear from Paul Bridges and a team of Parexel regulatory, market access and biostatistical experts as they explore considerations to de-risk trials through advanced planning and adaptive trial design. Create success by planning for it. Read our latest #NovelInsights article below and subscribe to stay up to date with our weekly newsletter. 🔗 https://lnkd.in/d5kw-KWx #ParexelBiotech #DrugDevelopment #ClinicalResearch #ClinicalTrials
-
-
In this edition of the New Medicines, Novel Insights newsletter, hear from Paul Bridges and a team of Parexel regulatory, market access and biostatistical experts as they explore considerations to de-risk trials through advanced planning and adaptive trial design. Create success by planning for it. Read our latest #NovelInsights article below and subscribe to stay up to date with our weekly newsletter. 🔗 https://lnkd.in/g8hygqhy #ParexelBiotech #DrugDevelopment #ClinicalResearch #ClinicalTrials
-
-
In this edition of the New Medicines, Novel Insights newsletter, hear from Paul Bridges and a team of Parexel regulatory, market access and biostatistical experts as they explore considerations to de-risk trials through advanced planning and adaptive trial design. Create success by planning for it. Read our latest #NovelInsights article below and subscribe to stay up to date with our weekly newsletter. 🔗 https://lnkd.in/e8aCNSWi #ParexelBiotech #DrugDevelopment #ClinicalResearch #ClinicalTrials
-
-
Baker Tilly's fourth annual life sciences industry forecast highlights key challenges in the life sciences industry, including increasing regulatory scrutiny, evolving reimbursement models, and pressures surrounding drug pricing. We will also touch on the importance of simplifying HCP engagement, leveraging technology to mitigate compliance risks, and turning industry risks into strategic opportunities for 2025 and beyond. Join us tomorrow for an engaging discussion!
-
In this edition of the New Medicines, Novel Insights newsletter, hear from Paul Bridges and a team of Parexel regulatory, market access and biostatistical experts as they explore considerations to de-risk trials through advanced planning and adaptive trial design. Create success by planning for it. Read our latest #NovelInsights article below and subscribe to stay up to date with our weekly newsletter. 🔗 https://lnkd.in/e8aCNSWi #ParexelBiotech #DrugDevelopment #ClinicalResearch #ClinicalTrials
-
